Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications
- PMID: 38079281
- PMCID: PMC10720825
- DOI: 10.2459/JCM.0000000000001553
Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications
Abstract
Background: Patients with atrial fibrillation (AF) undergoing transcatheter aortic valve implantation (TAVI) have been associated with worse short-term outcomes compared with patients in sinus rhythm but data on long-term outcomes are limited. The aim of our study was to evaluate the association between AF and short- and long-term outcomes in patients undergoing TAVI.
Methods: We retrospectively evaluated patients undergoing TAVI between 2012 and 2022 in four tertiary centres. Two different analyses were conducted: (i) in-hospital and (ii) postdischarge analysis. First, we evaluated the association between preexisting AF and short-term outcomes according to VARC-3 criteria. Second, we analyzed the association between AF at discharge (defined as both preexisting and new-onset AF occurring after TAVI) and long-term outcomes at median follow-up of 3.2 years (i.e. all-cause death, hospitalization and major adverse cardiovascular events).
Results: A total of 759 patients were initially categorized according to the presence of preexisting AF (241 vs. 518 patients). The preexisting AF group had a higher occurrence of acute kidney injury [odds ratio (OR) 1.65; 95%confidence interval ( CI) 1.15-2.38] and major bleeding (OR 1.86, 95% CI 1.06-3.27). Subsequently, the population was categorized according to the presence of AF at discharge. At the adjusted Cox regression analysis, AF was independently associated with an increased risk of all-cause death and cardiovascular hospitalization [adjusted hazard ratio (aHR) 1.42, 95% CI 1.09-1.86], all-cause death and all-cause hospitalization (aHR 1.38, 95% CI 1.06-1.78) and all-cause hospitalization (aHR 1.59, 95% CI 1.14.2.22).
Conclusions: In a real-world cohort of patients undergoing TAVI, the presence of AF (preexisting and new-onset) was independently associated with both short- and long-term adverse outcomes.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Italian Federation of Cardiology.
Conflict of interest statement
G.B. received small speaker's fees from Boston, Boehringer, Bayer, Daiichi-Sankyo, Janssen and Sanofi, outside of the submitted work. The other authors declare no conflict of interest.
Figures
References
-
- Pancaldi E, Cimino G, Metra M, Adamo M. What we have learnt in valvular heart disease from our journal. J Cardiovasc Med 2022; 23:427–429. - PubMed
-
- Vahanian A, Beyersdorf F, Praz F, et al. . 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43:561–632. - PubMed
-
- Sgura FA, Arrotti S, Monopoli D, et al. . Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation. Intern Emerg Med 2022; 17:369–376. - PubMed
-
- Massussi M, Adamo M, Rosato S, et al. . Functional and metabolic frailty predicts mortality in patients undergoing TAVI: insights from the OBSERVANT II study. Eur J Intern Med 2022; 106:90–96. - PubMed
-
- Mack MJ, Leon MB, Thourani VH, et al. . Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380:1695–1705. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
